🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Lipoprotein Disorder

Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions NCT06676046n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) Assessment of Compliance With European and French Guidelines for the Management of Dyslipidaemias NCT03449784n/a1 site📍 Montpellier University Hospital, Montpellier · Tests: Detection of patients with dyslipidemia Insulin Therapy and Lipoproteins' Profile in Type 1 Diabetes. NCT02306005n/a1 site📍 Poznan Poznan University of Medical Sciences OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events NCT07136012Phase 3252 sites📍 Alexander City📍 Birmingham📍 Birmingham Amgen · Tests: Olpasiran, Placebo Assessment of Lipoprotein(a) and Endogenous Fibrinolysis in Atherosclerotic Cardiovascular Disease/Aortic Valve Disease NCT06126367n/a1 site📍 Stevenage East and North Hertfordshire NHS Trust · Tests: Thrombotic assessment, Measurement of Lp(a) Lipoprotein Kinetics in T1D NCT05179954NA1 site📍 Columbia University of Missouri-Columbia · Tests: Metabolic testing Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk Adults NCT07575438Phase 21 site📍 Montreal May Faraj, PDt, PhD · Tests: Fish Oil, Fish Oil, Corn oil control Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia NCT06597019Phase 366 sites📍 San Francisco📍 San Francisco📍 Washington D.C. Novartis Pharmaceuticals · Tests: Inclisiran, Placebo A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis NCT05646381Phase 2140 sites📍 Huntsville📍 Beverly Hills📍 Beverly Hills Novartis Pharmaceuticals · Tests: Pelacarsen (TQJ230) 80mg, Matching placebo Mechanism of Ketogenic Diet-Induced Hypercholesterolemia NCT06894004NA1 site📍 St Louis Washington University School of Medicine · Tests: Ketogenic Diet, Control Diet A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD) NCT07619820Phase 11 site📍 Beijing CSL Behring · Tests: CSL300, Placebo Effect of Consuming n-3 Polyunsaturated Fatty Acids Rich Foods on Triglyceride Concentration and Lipoprotein Composition NCT07004777NA1 site📍 Mexico City Instituto Nacional de Ciencias Medicas y Nutricion Salvador… · Tests: Isocaloric diet including chia and pumpkin seeds, Isocaloric diet AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION) NCT07577609n/a1 site📍 Galway University of Galway Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids NCT04485871NA1 site📍 Montreal Institut de Recherches Cliniques de Montreal · Tests: Omega-3 fatty acids A Study of SRSD216 in Patients With Elevated Lipoprotein (a) NCT07172646Phase 1, Phase 21 site📍 Beijing Sirius Therapeutics Co., Ltd. · Tests: SRSD216 injection, Placebo LCAT (Lecithin Cholesterol Acyl Transferase) Natural History Study NCT06217588n/a1 site📍 Philadelphia University of Pennsylvania · Tests: Demographics, diagnosis type, genotype, lipid profile, renal function profile, treatment allocation, ophthalmology exam… A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk NCT07613294Phase 358 sites📍 La Jolla📍 Northridge📍 Torrance Eli Lilly and Company · Tests: Lepodisiran, Placebo Atlantic Lipid Lowering Treatment Optimization Program NCT06439654NA2 sites📍 Clark📍 Springfield Atlantic Health System · Tests: Supportive care Triglyceride-rich LIPoproteins and INflammatory Cytokines After Oral FAT Loading as Potential Early Biomarkers of the Risk of Progression Towards DIABETES and Development of Complications. LIPINFAT Diabetes Study. NCT07602023n/a2 sites📍 Ferrara📍 Poggio Renatico Angelina Passaro · Tests: Oral Fat Load Test Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial NCT07293260Phase 340 sites📍 Bridgeport📍 Jacksonville📍 Overland Park Amgen · Tests: Olpasiran, Placebo Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels NCT06496243Phase 21 site📍 Philadelphia NewAmsterdam Pharma · Tests: obicetrapib 10 mg + obicetrapib/evolocumab 140 mg Q 2 weeks A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients. NCT07619131Phase 3152 sites📍 Dothan📍 Chandler📍 Phoenix AstraZeneca · Tests: Laroprovstat, Rosuvastatin 1, Rosuvastatin 2, Laroprovstat/Rosuvastatin 1, Placebo to match rosuvastatin Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study) NCT07359105NA2 sites📍 Seoul📍 Seoul Sin Gon Kim · Tests: Moderate-intensity statin monotherapy, Ezetimibe or ezetimibe-statin combination therapy Heart CT Imaging to Detect Early Coronary Artery Disease in First-Degree Relatives With High or Low Lipoprotein(a) Identified Through Family Screening NCT06995183n/a1 site📍 Amsterdam E.S.stroes A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease NCT06164730Phase 127 sites📍 Dothan📍 Pomona📍 Boca Raton Verve Therapeutics, Inc. · Tests: VERVE-102 Causes and Natural History of Dyslipidemias NCT00353782n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke NCT06649240NA46 sites📍 Ansan📍 Anyang📍 Busan Seoul National University Hospital · Tests: Statins and/or Ezetimibe, PCSK9 inhibitor Test 2 Treat: Can we Improve the Testing and Treatment of High Cholesterol in Patients Who Have Been Hospitalized for a Cardiac Event by Providing Education to Doctors and Patients? NCT06471036NA1 site📍 Minneapolis Duke University · Tests: Care Champion Intervention Cardiovascular Risk in Children With Chronic Conditions Study NCT07086989n/a3 sites📍 Budapest📍 Budapest📍 Budapest Semmelweis University Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome NCT07824323Phase 41 site📍 Taipei Taipei Medical University Hospital · Tests: bempedoic acid, Ezetimibe, High-Intensity Statin Therapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy